Frequencies of an Immunogenic HER-2/neu Epitope of CD8+T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer

Goulielmaki, M; Stokidis, S; Anagnostou, T; Voutsas, IF; Gritzapis, AD; Baxevanis, CN; Fortis, SP

Fortis, SP (通讯作者)，St Savas Canc Hosp, Canc Immunol & Immunotherapy Ctr, Canc Res Ctr, Athens 11522, Greece.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023; 24 (6):

Abstract

HER-2/neu is the human epidermal growth factor receptor 2, which is associated with the progression of prostate cancer (PCa). HER-2/neu-specific T cel......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索